Middlesex Joins Mayo Clinic Convalescent Plasma Program
MIDDLETOWN — Middlesex Health has joined a national initiative, led by Mayo Clinic, that is investigating the use of convalescent plasma during the COVID-19 pandemic. The initiative is using convalescent plasma from patients who have fully recovered from COVID-19 with the hope that antibodies in the plasma can help hospitalized patients who have COVID-19.
The success of the program depends on people who have recovered from COVID-19 donating their blood. The convalescent plasma is being collected by various blood banks, and eligible individuals are encouraged to donate. More information about donating convalescent plasma can be found at www.uscovidplasma.org/donate.
“By donating your plasma, you may be able to help others who are diagnosed with COVID-19,” says Middlesex Health President and CEO Vincent G. Capece, Jr. “If you are eligible and able, please consider donating. This is your opportunity to make a difference during this pandemic.”
Blood banks throughout the country have already started to collect convalescent plasma for this study and for similar studies led by other institutions. This has made it possible for Middlesex Health to begin administering plasma to patients, and it began enrolling patients in the program today.
“Without a vaccine or an FDA-approved medicine to treat COVID-19, the medical community must do its research and do what it can to try to save lives,” Capece says. “This convalescent plasma program is an important step, and Middlesex Health is happy to be part of the effort. We strive to provide the highest quality care and to make a difference in our community, and we are doing just that by participating in this program.”
As a member of the Mayo Clinic Care Network, Middlesex Health regularly collaborates with Mayo Clinic on many matters, including clinical care. This relationship provides Middlesex with access to information, knowledge and expertise from Mayo Clinic, the No. 1 hospital in the country according to U.S. News & World Report. The convalescent plasma program is yet another example of this collaboration.
More Press Releases
Today, the first 12 Middlesex Health employees received the Pfizer-BioNTech COVID-19 vaccine.
Effective immediately, all Middlesex Health service locations are closed to visitors except for those making compassionate visits, and support persons accompanying patients with disabilities.